Syphilis is a sexually transmitted disease that mostly results inchronic bacterial infection of bacterium treponem pallidum. It can spread through direct contact with the syphilis sore during vaginal, anal or oral sex. Moreover, it can also be causedfrom an infected mother to her unborn child. The symptoms of this disease is divided into stages like primary, secondary, latent syphilis and late syphilis. The primary and secondary stages show very mild indications such as non-itchy body rashes, fever and harmless bump on testicles. While in latent and late stages, more severe symptoms appear like difficulty in coordination muscle movement, blindness and dementia (mental disorder) and if untreated, it may cause long term health complications or death. Syphilis is treated with antibiotics such as penicillin and tetracycline.
One of the major factors influencing the market growth is consistent rise in the number of syphilis affected patients. According to the Centre for Disease Control and Prevention, there were 49,000 new cases reported of syphilis in 2012. In addition, adoption of new technologies and development of novel assays drives the growth of this market during the forecast period. However, high cost of diagnostic test and regulatory constraints are the major restraining factors for the growth of this market.
Download exclusive Sample of this Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=2140
The market of Syphilis Diagnostics can be segmented on the basis of:
- By Technology
- Molecular Diagnostics
- Monoclonal Antibodies
- Flow Cytometry
- Diagnostic Imaging
- Gel Microdroplets
- Differential Light Scattering
- End Users
- Commercial/ Private Labs
- Blood Banks
- Public Health Labs
- Physician Offices
Geographically, North America and Europe dominate the global syphilis diagnostic testing marketdue to increasing incidences of unprotected sex. According to the Centre for Disease Control and Prevention, more than 55,000 people in the United States are infected by syphilis annually.In addition, Asia-Pacific countries such as India and China, South East Asia are the emerging regions for the global Syphilis Diagnosticsmarket due to high prevalence of these diseases (i.e. sexually transmitted diseases) coupled with increasing healthcare awareness.
Some of the major players competing in Syphilis Diagnostics market are Abbott Laboratories, Affymetrix, Beckman Coulter and Company, Cephaid, Bio-Rad Laboratories, Inc., BioMerieux, Diamedix Corporation, DiaSorin, Novartis International AG, Eiken Chemical Co., Ltd., Ortho Clinical Diagnostics, F. Hoffman-La Roche, Ltd., ThermoFisher Scientific, Quagen and SeraCareLifeSciences.
Transparency Market Research
90 State Street,
NY – 12207
USA – Canada Toll Free 866-552-3453